Eduardo Dunayevich

Eduardo Dunayevich is a seasoned medical professional with extensive experience in the pharmaceutical and biotechnology sectors. Current roles include Vice President and VMAT2 Franchise Leader at Neurocrine Biosciences, and previous positions feature Vice President of Clinical Science at Greenwich Biosciences, Executive Vice President and Chief Medical Officer at Annexon Biosciences, and roles at Takeda as Vice President and Global Product Lead, as well as Executive Director of Neuroscience Clinical Development. Eduardo holds a Doctor of Medicine (MD) degree from the University of Cincinnati College of Medicine, complemented by undergraduate education at the University of Buenos Aires.